omega-n-methylarginine has been researched along with gamma-glu-asp in 1 studies
Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (gamma-glu-asp) | Trials (gamma-glu-asp) | Recent Studies (post-2010) (gamma-glu-asp) |
---|---|---|---|---|---|
4,411 | 344 | 336 | 21 | 0 | 6 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
de Leeuw, PW; Doevendans, PA; Kroon, AA; Smits, P; Spiering, W; Veldman, BA; Vervoort, G | 1 |
1 other study(ies) available for omega-n-methylarginine and gamma-glu-asp
Article | Year |
---|---|
The Glu298Asp polymorphism of the NOS 3 gene as a determinant of the baseline production of nitric oxide.
Topics: Adolescent; Adult; Alleles; Dipeptides; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Forearm; Genotype; Humans; Infusions, Intra-Arterial; Male; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Norepinephrine; omega-N-Methylarginine; Polymorphism, Genetic; Reference Values; Regional Blood Flow; Vasoconstrictor Agents | 2002 |